Publications of Pawel Zmora

Kupke, S. Y., Riedel, D., Frensing, T., Zmora, P., & Reichl, U. (2019)A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its GenomeJournal of Virology, 93 (4), 01786-18doi: 10.1128/JVI.01786-18.

Rüdiger, D., Kupke, S. Y., Laske, T., Zmora, P., & Reichl, U. (2019)Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditionsPLoS Computational Biology, 15 (2), e1006819doi: 10.1371/journal.pcbi.1006819.

Kupke, S. Y., Riedel, D., Frensing, T., Zmora, P., & Reichl, U. (2018)Single-cell analysis uncovers a novel influenza A virus-derived defective interfering particle for antiviral therapyIn: Vaccine Technology VII, 133.

Rüdiger, D., Kupke, S. Y., Zmora, P., & Reichl, U.Multiscale model of influenza virus infection predicts viral release dynamics in cell cultures for a wide range of infection conditionsPresented at: 3rd Workshop on Virus DynamicsHeidelberg, Germany, October 6, 2017.

Zmora, P.Vaccines against emerging infectious diseases (Ebola, SARS, MERS, influenza) - future or present?Presented at: Tropical & Parasitic Disease ConferencePoznan, Poland, September 14, 2017.

Zmora, P., Moldenhauer, A. S., Erdelt, S., Dahlmann, F., Sewald, K., Zhao, Y., Bruns, S., & Poehlmann, S.Nafamostat is a new potent inhibitor of trypsin-independent influenza A viruses spreadPresented at: 27^th Annual Meeting of the Society for VirologyMarburg, Germany, March 22, 2017.

Kupke, S. Y., Frensing, T., Zmora, P., & Reichl, U. (2020)Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use.